Target intelligence / Profile preview

Respiratory syncytial virus antigen, glycoprotein G, nucleoprotein N, matrix protein M2-1

01

Overview

The target as written—"Respiratory syncytial virus antigen, glycoprotein G, nucleoprotein N, matrix protein M2-1"—is a conflation of multiple distinct RSV proteins, not a single canonical target. Each protein plays a distinct structural and functional role in the viral lifecycle: Respiratory syncytial virus glycoprotein G (RSV G) is a membrane-bound viral surface protein involved in host cell attachment via interaction with the CX3CR1 receptor and glycosaminoglycans, and it modulates host immune responses. Nucleoprotein N (RSV N) is the principal component of the viral nucleocapsid, essential for genome protection and replication. Matrix protein M2-1 (RSV M2-1) is a transcription processivity factor critical for efficient RSV RNA synthesis, functioning as a cofactor for the viral polymerase complex. While all contribute to RSV infection, they must be considered as separate entities for structured data purposes.

02

Mechanism of action

Not applicable as this is a conflated entity; mechanisms of action are specific to individual protein components (e.g., antibodies targeting G protein block viral attachment to host cells, neutralize the virus, and modulate host immune response).

03

Disease associations

Respiratory syncytial virus infection
04

Safety considerations

Safety concerns relate to targeting individual protein components, especially RSV G protein (e.g., historical concerns about immunopathology/vaccine-enhanced disease and variable immunogenicity). No known safety concerns unique to targeting N or M2-1 as they have not been successfully targeted clinically.
05

Biomarkers

Antigenic biomarkers for RSV infection diagnosis

Beyond the preview

Go deeper on Respiratory syncytial virus antigen, glycoprotein G, nucleoprotein N, matrix protein M2-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respiratory syncytial virus antigen, glycoprotein G, nucleoprotein N, matrix protein M2-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call